RLYB
Rallybio·NASDAQ
--
--(--)
--
--(--)
RLYB fundamentals
During Q4 2025, Rallybio (RLYB) reported revenue of 222.00K, a YoY change of 484.21%. Net income was -5.85M, a YoY change of 47.01%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | 299.00K -- | 299.00K -- | 38.00K -- | 212.00K -- | 212.00K -29.10% | 212.00K -29.10% | 222.00K +484.21% | 858.00K -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 299.00K -- | 299.00K -- | 38.00K -- | 212.00K -- | 212.00K -29.10% | 212.00K -29.10% | 222.00K +484.21% | 858.00K -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 3.84M -- | 4.66M -- | 6.71M -- | 10.09M -- | 12.82M +233.61% | 10.53M +125.87% | 9.98M +48.75% | 12.31M +22.07% | 14.32M +11.65% | 17.61M +67.28% | 18.86M +88.96% | 17.09M +38.80% | 18.37M +28.33% | 20.08M +14.01% | 19.36M +2.67% | 21.11M +23.53% | 19.79M +7.69% | 17.33M -13.69% | 12.37M -36.14% | 11.65M -44.84% | 9.88M -50.06% | 10.27M -40.76% | 7.14M -42.28% | 6.63M -43.04% | 33.92M -- |
Selling, General and Administrative Expenses | 1.93M -- | 1.57M -- | 1.58M -- | 2.59M -- | 3.79M +96.12% | 3.71M +136.43% | 5.02M +217.78% | 6.22M +139.93% | 6.67M +76.13% | 7.48M +101.43% | 6.75M +34.44% | 6.30M +1.27% | 7.17M +7.53% | 6.95M -7.01% | 6.08M -10.00% | 5.19M -17.62% | 6.85M -4.48% | 4.39M -36.89% | 4.13M -32.10% | 4.26M -17.87% | 4.16M -39.32% | 4.20M -4.40% | 2.99M -27.42% | 2.98M -30.09% | 14.32M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 7.67M -- | -- -- | -- -- | -- -- | 18.74M +144.22% | -- -- | -- -- | -- -- | 27.20M +45.13% | -- -- | -- -- | 6.08M -- | 5.19M -80.92% | 6.85M -- | 4.39M -- | 4.13M -32.10% | 4.26M -17.87% | 4.16M -39.32% | 4.20M -4.40% | 2.99M -27.42% | 2.98M -30.09% | 14.32M -- |
Research and Development Expenses | 1.91M -- | 3.09M -- | 5.13M -- | 7.50M -- | 9.04M +372.40% | 6.82M +120.50% | 4.96M -3.31% | 6.09M -18.69% | 7.65M -15.37% | 10.14M +48.69% | 12.11M +144.15% | 10.79M +77.11% | 11.20M +46.47% | 13.13M +29.51% | 13.29M +9.73% | 15.92M +47.54% | 12.94M +15.48% | 12.95M -1.40% | 8.24M -37.99% | 7.38M -53.62% | 5.72M -55.74% | 6.07M -53.08% | 4.14M -49.72% | 3.65M -50.51% | 19.60M -- |
Operating Income | -3.84M -- | -4.66M -- | -6.71M -- | -10.09M -- | -12.82M -233.61% | -10.53M -125.87% | -9.98M -48.75% | -12.31M -22.07% | -14.32M -11.65% | -17.61M -67.28% | -18.86M -88.96% | -17.09M -38.80% | -18.37M -28.33% | -20.08M -14.01% | -19.36M -2.67% | -21.11M -23.53% | -19.79M -7.69% | -17.04M +15.18% | -12.07M +37.69% | -11.61M +45.02% | -9.67M +51.13% | -10.06M +40.96% | -6.92M +42.61% | -6.41M +44.76% | -33.06M -- |
Non-Operating Income (Loss) | -53.00K -- | -231.00K -- | -445.00K -- | -430.00K -- | -451.00K -750.94% | -597.00K -158.44% | -215.00K +51.69% | -102.00K +76.28% | -180.00K +60.09% | 32.00K +105.36% | 490.00K +327.91% | 888.00K +970.59% | 1.06M +686.67% | 1.45M +4440.63% | 989.00K +101.84% | 870.00K -2.03% | 758.00K -28.22% | 799.00K -45.01% | 600.00K -39.33% | 564.00K -35.17% | 231.00K -69.53% | 354.00K -55.69% | 22.94M +3723.50% | 560.00K -0.71% | 24.09M -- |
Income (Loss) from Affiliates | -148.00K -- | -335.00K -- | -526.00K -- | -513.00K -- | -482.00K -225.68% | -468.00K -39.70% | -332.00K +36.88% | -223.00K +56.53% | -390.00K +19.09% | -338.00K +27.78% | -133.00K +59.94% | -214.00K +4.04% | -563.00K -44.36% | -217.00K +35.80% | -648.00K -387.22% | -613.00K -186.45% | -685.00K -21.67% | -487.00K -124.42% | -637.00K +1.70% | -430.00K +29.85% | -587.00K +14.31% | -287.00K +41.07% | 0 +100.00% | 0 +100.00% | -874.00K -- |
Income (Loss) from Joint ventures | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -648.00K -- | 1.43M -- | -685.00K -- | -487.00K -- | -- -- | -- -- | -587.00K +14.31% | -287.00K +41.07% | -- -- | -- -- | -- -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 251.00K -- | -561.00K -- | -- -- | -- -- | 22.48M +8855.78% | -22.77M -3959.00% | -- -- |
Other Non-Operating Income (Loss) | 52.00K -- | 69.00K -- | 52.00K -- | 68.00K -- | 24.00K -53.85% | -142.00K -305.80% | 105.00K +101.92% | 109.00K +60.29% | 113.00K +370.83% | 100.00K +170.42% | 98.00K -6.67% | 31.00K -71.56% | 73.00K -35.40% | 62.00K -38.00% | 92.00K -6.12% | 35.00K +12.90% | 167.00K +128.77% | 143.00K +130.65% | -- -- | 744.00K +2025.71% | 174.00K +4.19% | 118.00K -17.48% | -- -- | 22.77M +2960.62% | -- -- |
Net Interest Expense | -43.00K -- | -35.00K -- | -29.00K -- | -15.00K -- | -7.00K +83.72% | -13.00K +62.86% | -12.00K +58.62% | -12.00K +20.00% | -97.00K -1285.71% | -270.00K -1976.92% | -525.00K -4275.00% | -1.07M -8825.00% | -1.55M -1493.81% | -1.61M -495.56% | -1.54M -194.29% | -1.45M -35.20% | -1.28M +17.46% | -1.14M +28.92% | -986.00K +36.18% | -811.00K +43.99% | -644.00K +49.53% | -523.00K +54.24% | -462.00K +53.14% | -560.00K +30.95% | -2.19M -- |
Interest Expense | 12.00K -- | 12.00K -- | 13.00K -- | 12.00K -- | 10.00K -16.67% | 0 -100.00% | 0 -100.00% | 0 -100.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | 55.00K -- | 47.00K -- | 42.00K -- | 27.00K -- | 17.00K -69.09% | 13.00K -72.34% | 12.00K -71.43% | 12.00K -55.56% | 97.00K +470.59% | 270.00K +1976.92% | 525.00K +4275.00% | 1.07M +8825.00% | 1.55M +1493.81% | 1.61M +495.56% | 1.54M +194.29% | 1.45M +35.20% | 1.28M -17.46% | 1.14M -28.92% | 986.00K -36.18% | 811.00K -43.99% | 644.00K -49.53% | 523.00K -54.24% | 462.00K -53.14% | 560.00K -30.95% | 2.19M -- |
Pretax Income From Continuing Operations | -3.90M -- | -4.89M -- | -7.16M -- | -10.52M -- | -13.28M -240.65% | -11.13M -127.41% | -10.20M -42.50% | -12.41M -18.05% | -14.50M -9.21% | -17.58M -58.02% | -18.37M -80.17% | -16.20M -30.51% | -17.32M -19.45% | -18.63M -5.95% | -18.37M -0.02% | -20.24M -24.93% | -19.03M -9.88% | -16.24M +12.85% | -11.47M +37.60% | -11.04M +45.44% | -9.44M +50.40% | -9.70M +40.24% | 16.02M +239.68% | -5.85M +47.01% | -8.98M -- |
Income Tax Expense | -16.00K -- | -- -- | 0 -- | 1.00K -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income Tax Adjustments | -- -- | -- -- | -- -- | -15.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -3.88M -- | -4.89M -- | -7.16M -- | -10.52M -- | -13.28M -242.05% | -11.13M -127.41% | -10.20M -42.50% | -12.41M -18.04% | -14.50M -9.21% | -17.58M -58.02% | -18.37M -80.17% | -16.20M -30.51% | -17.32M -19.45% | -18.63M -5.95% | -18.37M -0.02% | -20.24M -24.93% | -19.03M -9.88% | -16.24M +12.85% | -11.47M +37.60% | -11.04M +45.44% | -9.44M +50.40% | -9.70M +40.24% | 16.02M +239.68% | -5.85M +47.01% | -8.98M -- |
Net Income Attributable to Owners of the Company | -3.88M -- | -4.89M -- | -7.16M -- | -10.52M -- | -13.28M -242.05% | -11.13M -127.41% | -10.20M -42.50% | -12.41M -18.04% | -14.50M -9.21% | -17.58M -58.02% | -18.37M -80.17% | -16.20M -30.51% | -17.32M -19.45% | -18.63M -5.95% | -18.37M -0.02% | -20.24M -24.93% | -19.03M -9.88% | -16.24M +12.85% | -11.47M +37.60% | -11.04M +45.44% | -9.44M +50.40% | -9.70M +40.24% | 16.02M +239.68% | -5.85M +47.01% | -8.98M -- |
Net Income Attributable to Common Stockholders | -3.88M -- | -4.89M -- | -7.16M -- | -10.52M -- | -13.28M -242.05% | -11.13M -127.41% | -10.20M -42.50% | -12.41M -18.04% | -14.50M -9.21% | -17.58M -58.02% | -18.37M -80.17% | -16.20M -30.51% | -17.32M -19.45% | -18.63M -5.95% | -18.37M -0.02% | -20.24M -24.93% | -19.03M -9.88% | -16.24M +12.85% | -11.47M +37.60% | -11.04M +45.44% | -9.44M +50.40% | -9.70M +40.24% | 16.02M +239.68% | -5.85M +47.01% | -8.98M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -122.00K -- | -249.00K -- | -63.00K -- | 220.00K -- | 153.00K +225.41% | -211.00K +15.26% | 64.00K +201.59% | 223.00K +1.36% | -86.00K -156.21% | -- -- | 240.00K +275.00% | -101.00K -145.29% | -21.00K +75.58% | -30.00K -- | 7.00K -97.08% | -6.00K +94.06% | -50.00K -- |
Total Comprehensive Income | -3.88M -- | -4.89M -- | -7.16M -- | -10.52M -- | -13.28M -242.05% | -11.13M -127.41% | -10.20M -42.50% | -12.41M -18.04% | -14.62M -10.13% | -17.83M -60.26% | -18.43M -80.79% | -15.98M -28.74% | -17.16M -17.41% | -18.84M -5.66% | -18.31M +0.67% | -20.02M -25.25% | -19.11M -11.36% | -16.24M +13.83% | -11.23M +38.69% | -11.14M +44.33% | -9.46M +50.51% | -9.73M +40.05% | 16.02M +242.73% | -5.86M +47.44% | -9.03M -- |
Total Comprehensive Income Attributable to Owners of the Company | -3.88M -- | -4.89M -- | -7.16M -- | -10.52M -- | -13.28M -242.05% | -11.13M -127.41% | -10.20M -42.50% | -12.41M -18.04% | -14.62M -10.13% | -17.83M -60.26% | -18.43M -80.79% | -15.98M -28.74% | -17.16M -17.41% | -18.84M -5.66% | -18.31M +0.67% | -20.02M -25.25% | -19.11M -11.36% | -16.24M +13.83% | -11.23M +38.69% | -11.14M +44.33% | -9.46M +50.51% | -9.73M +40.05% | 16.02M +242.73% | -5.86M +47.44% | -9.03M -- |
Basic EPS | -1.97 -- | -1.85 -- | -0.32 -- | -- -- | -0.6 +69.54% | -0.49 +73.51% | -0.37 -15.62% | -0.39 -- | -0.48 +20.00% | -0.57 -16.33% | -0.6 -62.16% | -0.43 -10.26% | -0.43 +10.42% | -0.46 +19.30% | -0.45 +25.00% | -0.54 -25.58% | -0.47 -9.30% | -0.37 +19.57% | -0.26 +42.22% | -0.27 +50.00% | -0.21 +55.32% | -0.22 +40.54% | 0.36 +238.46% | -0.14 +48.15% | -0.21 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.45 -- | -- -- | -0.47 -- | -0.37 -- | -0.26 +42.22% | -- -- | -0.21 +55.32% | -0.22 +40.54% | 0.36 +238.46% | -- -- | -- -- |
Diluted EPS | -1.97 -- | -1.85 -- | -0.32 -- | -- -- | -0.6 +69.54% | -0.49 +73.51% | -0.37 -15.62% | -- -- | -0.48 +20.00% | -0.57 -16.33% | -0.6 -62.16% | -- -- | -0.43 +10.42% | -0.46 +19.30% | -0.45 +25.00% | -- -- | -0.47 -9.30% | -0.37 +19.57% | -0.26 +42.22% | -- -- | -0.21 +55.32% | -0.22 +40.54% | 0.36 +238.46% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.45 -- | -- -- | -0.47 -- | -0.37 -- | -0.26 +42.22% | -- -- | -0.21 +55.32% | -0.22 +40.54% | 0.36 +238.46% | -- -- | -- -- |
You can ask Aime
What is Rallybio's gross profit margin?What is the market's earnings forecast for Rallybio next quarter?Did Rallybio beat or miss consensus estimates last quarter?What is Rallybio's latest dividend and current dividend yield?What were the key takeaways from Rallybio's earnings call?What factors drove the changes in Rallybio's revenue and profit?What were the key takeaways from Rallybio’s earnings call?What guidance did Rallybio's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
